Archive for the ‘japan retractions’ Category
The most recent notice mentions the investigation, and specifies that the first author, Satoshi Hagiwara, was responsible for the problematic figures in the paper. Hagiwara is also the first author on two retracted papers we reported on last year; one of the earlier retractions also mentions the investigation, but does not assign responsibility to any particular author. All three papers share three authors.
The retraction notice for “Continuous Hemodiafiltration Therapy Ameliorates LPS-Induced Systemic Inflammation in a Rat Model,” published in the Journal of Surgical Research, explains the issues with the paper:
Our count for Kato has now risen to 39; we added five retraction notices to our count for Kato last month. These notices follow an investigation at the University of Tokyo, where Kato used to work, which found 43 papers contained “likely altered or forged materials,” according to a 2013 news article from The Asahi Shimbun.
Here’s the retraction note for “1alpha,25(OH)2D3-induced DNA methylation suppresses the human CYP271B1 gene,” published in Molecular and Cellular Endocrinology:
A researcher accused of misconduct by an anonymous Japanese blogger has corrected a 2003 paper in Circulation Research, after providing a university investigation with the original source files.
Allegations of fraud have dogged Shokei Kim-Mitsuyama for years, and even caused him to step down from his position as editor in chief at another journal. However, Kim-Mitsuyama and his colleagues call the latest correction a “mistake,” which didn’t affect any of the paper’s conclusions.
Readers likely know by now how easy it is for this to happen, as we frequently report on retractions due to similar reasons. Like other instances of mistaken cell identity, the authors of this 2013 paper realized the mistake following further tests of the bacteria used in the experiment.
The former University of Tokyo endocrinologist recently earned another retraction, for a paper in Archives of Biochemistry and Biophysics that contained image manipulation. As we’ve noted before, Kato resigned from the university in 2012 as it investigated his work for misconduct; in 2013 a Japanese newspaper reported that the investigation had found 43 papers from his lab contained “likely altered or forged materials.”
In addition to the new retraction, we’ve dug up four others for Kato from the past few years, plus one correction. Two of the retraction notices mention an investigation at the University of Tokyo.
First, the retraction note for “Multiple co-activator complexes support ligand-induced transactivation function of VDR,” published in December:
One describes a case in which the researchers removed a mass from a 64-year-old woman’s small intestine; the other describes how the authors removed a growth from a patient’s pancreas. They conclude that the surgery techniques used — like a laparoscopic pancreaticoduodenectomy, a take on the “Whipple Procedure” — can be “feasible, safe, and effective” in certain patients.
The papers share several authors, including a first author, Akihiro Cho, who’s affiliation on the papers is Chiba Cancer Center Hospital in Japan. They also share a retraction note, which explains how the journal learned of the issue:
The first author of two high-profile Nature retractions about a technique to easily create stem cells has lost another paper in Nature Protocols.
After learning of concerns that two figures are “very similar” and “some of the error bars look unevenly positioned,” the rest of the authors were unable to locate the raw data, according to the note. The journal could not reach Obokata for comment before publishing the retraction.
“Reproducible subcutaneous transplantation of cell sheets into recipient mice” has been cited 21 times, according to Thomson Reuters Web of Science. It was published in June 2011, soon after Obokata earned her PhD.
Here’s the note:
We don’t have a lot of information on a recent retraction of a 2001 paper published in a Japanese journal — just a brief and strongly worded note explaining that it follows “a strict, extensive, and judicious review.”
The paper, retracted 14 years after it was published, describes patients in Okinawa, Japan who developed severe symptoms following infection by bacteria belonging to the Aeromonas genus. One example:
The one patient was a 15-year-old high school girl student, who had been healthy in her school life, was admitted to the hospital with a sudden onset of left thigh muscle pain and swelling. She subsequently went into septic shock and died one day after admission. Pathological examination on autopsy revealed massive gas formation, skin bullas and ulcers, and extensive severe soft tissue damage throughout the body.
“Aeromonas species infection with severe clinical manifestation in Okinawa, Japan-association with gas gangrene” has been cited three times, according to Thomson Scientific’s Web of Knowledge. It was published in a Japanese journal, Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi — which translates to the Journal of the Association for Rapid Method and Automation in Microbiology.
Two of the papers are on bone regeneration; one is about targeting tumors. In addition to issues with figures,
two one of the retraction notes explain that the papers contain “widespread plagiarism of text” from other papers by the researcher, Hossein Hosseinkhani.
Hosseinkhani is currently affiliated with the National Taiwan University of Science and Technology; when he did the work in the now retracted papers, published in 2004 and 2007, he was based at Kyoto University Hospital and then National Institute for Materials Science in Japan.
The Journal of Controlled Release published
all three two of the papers. Here’s the retraction note for “Bone regeneration through controlled release of bone morphogenetic protein-2 from 3-D tissue engineered nano-scaffold,” which has been cited 118 times, according to Thomson Scientific’s Web of Knowledge.
Nearly four years after an analysis of more than 160 papers by Yoshitaka Fujii concluded the chances the data were authentic were infinitesimally small, the British Journal of Ophthalmology has decided to formally retract one of the papers included in that review.
The name Yoshitaka Fujii should ring a bell — an alarm bell, in fact — for our readers. He’s firmly listed in the number one spot on our leaderboard, with more than 180 retractions.
The recently retracted paper — “Ramosetron compared with granisetron for the prevention of vomiting following strabismus surgery in children” — has been included in that retraction total for years, because it was part of a seminal 2012 analysis by J.B. Carlisle that put the odds of data occurring naturally in some of Fujii’s papers at: Read the rest of this entry »